Transcriptomics

Dataset Information

0

A Lactate-induced SREBF2-dependent genetic program drives an immunotolerant dendritic cell population during cancer progression [CITEseq]


ABSTRACT: Dendritic cells (cDCs) are essential mediators of anti-tumor immunity. Cancers have developed mechanisms to render DCs dysfunctional within the tumor microenvironment. Utilizing CD63 as a unique surface marker, we demonstrate that mature regulatory DCs (mregDCs) suppress DC antigen cross-presentation while driving TH2 and regulatory T cell differentiation within tumor-draining lymph node tissues. Transcriptional and metabolic studies show that mregDC functionality is dependent upon the mevalonate biosynthetic pathway and the master transcription factor, SREBP2. Melanoma-derived lactate activates DC SREBP2 in the tumor microenvironment (TME) and drives mregDC development from conventional DCs. DC-specific genetic silencing and pharmacologic inhibition of SREBP2 promotes anti-tumor CD8+ T cell activation and suppresses melanoma progression. CD63+ mregDCs reside within the sentinel lymph nodes of melanoma patients. Collectively, this work describes a tumor-driven SREBP2-dependent program that promotes CD63+ mregDC development and function while serving as a promising therapeutic target for overcoming immune tolerance in the TME.

ORGANISM(S): Mus musculus

PROVIDER: GSE253586 | GEO | 2024/05/13

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-05-13 | GSE253588 | GEO
2024-05-13 | GSE253592 | GEO
2024-05-13 | GSE253590 | GEO
2024-05-13 | GSE253589 | GEO
2024-07-18 | GSE234182 | GEO
2018-10-26 | PXD005539 | Pride
2023-02-22 | GSE219197 | GEO
2023-09-01 | GSE222080 | GEO
2023-09-16 | PXD045429 |
2023-09-22 | GSE243483 | GEO